Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03715959 · ClinicalTrials.gov registry record · NA
Nipple Aspirate Fluid in Detecting Breast Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03715959 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 2 participants.
The verdict
NCT03715959, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This trial studies nipple aspirate fluid in detecting breast cancer. Nipple aspirate fluid may better detect breast cancer earlier than current methods used for screening such as mammograms and breast examinations.
Interventions
- PROCEDURE Biospecimen Collection
- PROCEDURE Aspiration of Breast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2024-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03715959
The ClinicalTrials.gov registry entry for NCT03715959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biospecimen Collection is the first listed.
NCT03715959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03715959 about?
NCT03715959 is a clinical study titled "Nipple Aspirate Fluid in Detecting Breast Cancer". This trial studies nipple aspirate fluid in detecting breast cancer. Nipple aspirate fluid may better detect breast cancer earlier than current methods used for screening such as mammograms and breast examinations.
What is the current status of trial NCT03715959?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2020-12-10. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT03715959?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Aspiration of Breast (PROCEDURE).
Who is sponsoring clinical trial NCT03715959?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.